Larry Eugene Overman
11Patents
3h-index
14Co-inventors
57Inventor score
Filing activity: Jun 21, 1984 → Oct 16, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9828342B2 | Isatin derivatives, pharmaceutical compositions thereof, and methods of use thereof | Chemistry; Metallurgy | 16 | Active |
| US9527868B2 | ETP derivatives | Emerging Cross-Sectional Technologies | 3 | Active |
| US5627169A | Selective antagonists for GABA.sub.rho receptor | Chemistry; Metallurgy | 3 | Expired |
| US10272093B2 | Use of H3K9me3 modulation for enhancing cognitive function | Chemistry; Metallurgy | 2 | Active |
| US9856273B2 | ETP derivatives | Emerging Cross-Sectional Technologies | 2 | Active |
| US10822353B2 | Dithio ETP derivatives | Emerging Cross-Sectional Technologies | 1 | Active |
| US10849910B2 | Use of H3K9me3 modulation for enhancing cognitive function | Chemistry; Metallurgy | 1 | Active |
| US11584760B2 | Dithio ETP derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US10246471B2 | ETP derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US4675325A | Synthesis of indolizidines related to the carditonic pumiliotoxin a alkaloids | Human Necessities | 0 | Expired |
| US11311551B2 | Use of H3K9me3 modulation for enhancing cognitive function | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.